Abivax SA (ABVX)
85.22
-1.79
(-2.06%)
USD |
NASDAQ |
Oct 08, 10:25
Abivax EPS Diluted (Quarterly) : -1.714 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.714 |
| March 31, 2026 | -0.7181 |
| December 31, 2025 | -1.215 |
| Date | Value |
|---|---|
| September 30, 2025 | -2.457 |
| June 30, 2025 | -0.865 |
| March 31, 2025 | -0.8696 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Poxel SA | -- |
| OSE Immunotherapeutics SA | -- |
| Cogent Biosciences, Inc. | -0.5636 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -136.54M |
| Total Expenses (Quarterly) | 136.54M |
| Enterprise Value | 6.486B |
| Earnings Yield | -7.16% |
| Normalized Earnings Yield | -5.900 |